Harada T - Search Results

1

A simplified procedure of nerve-sparing radical hysterectomy.

Komatsu H, Okawa M, Hikino K, Iida Y, Osaku D, Kudoh A, Chikumi J, Sato S, Oishi T, Harada T. Komatsu H, et al. Among authors: harada t. J Obstet Gynaecol Res. 2022 Mar;48(3):766-773. doi: 10.1111/jog.15154. Epub 2022 Jan 20. J Obstet Gynaecol Res. 2022. PMID: 35052017

2

Ultrasound-guided local injection of methotrexate to treat an invasive hydatidiform mole.

Tsukihara S, Harada T, Terakawa N. Tsukihara S, et al. Among authors: harada t. J Obstet Gynaecol Res. 2004 Jun;30(3):202-4. doi: 10.1111/j.1447-0756.2004.00179.x. J Obstet Gynaecol Res. 2004. PMID: 15210043

3

Cervical Ureaplasma urealyticum colonization might be associated with increased incidence of preterm delivery in pregnant women without prophlogistic microorganisms on routine examination.

Mitsunari M, Yoshida S, Deura I, Horie S, Tsukihara S, Harada T, Irie T, Terakawa N. Mitsunari M, et al. Among authors: harada t. J Obstet Gynaecol Res. 2005 Feb;31(1):16-21. doi: 10.1111/j.1447-0756.2005.00246.x. J Obstet Gynaecol Res. 2005. PMID: 15669986

4

Inhibiting the mTOR pathway synergistically enhances cytotoxicity in ovarian cancer cells induced by etoposide through upregulation of c-Jun.

Itamochi H, Oishi T, Shimada M, Sato S, Uegaki K, Naniwa J, Sato S, Nonaka M, Terakawa N, Kigawa J, Harada T. Itamochi H, et al. Among authors: harada t. Clin Cancer Res. 2011 Jul 15;17(14):4742-50. doi: 10.1158/1078-0432.CCR-11-0190. Epub 2011 May 24. Clin Cancer Res. 2011. PMID: 21610153

5

Area under the curve calculation of nedaplatin dose used in combination chemotherapy with irinotecan in a phase I study of gynecologic malignancies.

Shimada M, Fujiwara H, Sato S, Oishi T, Itamochi H, Machida S, Takei Y, Harada T, Suzuki M, Kigawa J. Shimada M, et al. Among authors: harada t. Cancer Chemother Pharmacol. 2012 Jul;70(1):33-8. doi: 10.1007/s00280-012-1885-z. Epub 2012 May 18. Cancer Chemother Pharmacol. 2012. PMID: 22610355 Clinical Trial.

6

Activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway overcomes cisplatin resistance in ovarian carcinoma cells.

Nonaka M, Itamochi H, Kawaguchi W, Kudoh A, Sato S, Uegaki K, Naniwa J, Sato S, Shimada M, Oishi T, Terakawa N, Kigawa J, Harada T. Nonaka M, et al. Among authors: harada t. Int J Gynecol Cancer. 2012 Jul;22(6):922-9. doi: 10.1097/IGC.0b013e31824f0b13. Int J Gynecol Cancer. 2012. PMID: 22672985

7

Establishment and characterization of a novel ovarian serous adenocarcinoma cell line, TU-OS-4, that overexpresses EGFR and HER2.

Itamochi H, Kato M, Nishimura M, Oishi T, Shimada M, Sato S, Naniwa J, Sato S, Nonaka M, Kudoh A, Terakawa N, Kigawa J, Harada T. Itamochi H, et al. Among authors: harada t. Hum Cell. 2012 Dec;25(4):111-5. doi: 10.1007/s13577-012-0048-1. Epub 2012 Dec 30. Hum Cell. 2012. PMID: 23274876

8

Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene.

Itamochi H, Kato M, Nishimura M, Oumi N, Oishi T, Shimada M, Sato S, Naniwa J, Sato S, Nonaka M, Kudoh A, Terakawa N, Kigawa J, Harada T. Itamochi H, et al. Among authors: harada t. Hum Cell. 2013 Sep;26(3):121-7. doi: 10.1007/s13577-013-0062-y. Epub 2013 Feb 21. Hum Cell. 2013. PMID: 23430509

9

Outcome of stage IB2-IIB patients with bulky uterine cervical cancer who underwent neoadjuvant chemotherapy followed by radical hysterectomy.

Uegaki K, Shimada M, Sato S, Deura I, Naniwa J, Sato S, Oishi T, Itamochi H, Harada T, Kigawa J. Uegaki K, et al. Among authors: harada t. Int J Clin Oncol. 2014 Apr;19(2):348-53. doi: 10.1007/s10147-013-0559-0. Epub 2013 Apr 17. Int J Clin Oncol. 2014. PMID: 23592280

10

Checkpoint kinase inhibitor AZD7762 overcomes cisplatin resistance in clear cell carcinoma of the ovary.

Itamochi H, Nishimura M, Oumi N, Kato M, Oishi T, Shimada M, Sato S, Naniwa J, Sato S, Kudoh A, Kigawa J, Harada T. Itamochi H, et al. Among authors: harada t. Int J Gynecol Cancer. 2014 Jan;24(1):61-9. doi: 10.1097/IGC.0000000000000014. Int J Gynecol Cancer. 2014. PMID: 24362713

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,103 results

Search Page